# Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

> **NCT00306735** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 75 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT00306735
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2016-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306735, "Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00306735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*